Advertisement

International Journal of Clinical Pharmacy

, Volume 39, Issue 6, pp 1220–1227 | Cite as

Quality of prescribing in community-dwelling elderly patients in France: an observational study in community pharmacies

  • E. Bourcier
  • F. Mille
  • V. Brunie
  • V. Korb-Savoldelli
  • C. Lafortune
  • M. Buyse
  • C. Fernandez
  • P. Hindlet
Research Article

Abstract

Background In order to ensure safer prescriptions in the elderly, lists of potentially inappropriate medications (PIMs) and guidelines have been introduced. Whereas the effectiveness of these measures has been well studied in hospitals, data are sparse for the community-dwelling patients. Objective To assess the quality of prescriptions among community-dwelling elderly patients, and potential associations between prescription patterns, patient characteristics and medication adherence. Setting Community pharmacies in France. Method We conducted a prospective observational study between January and June 2013. Patients aged 75 and over coming to the community pharmacy with a prescription from a general practitioner were invited to participate to the study. The compliance of the prescription was assessed with regards to Beers Criteria and French Health Authority guidelines (FHA) for prescription in the elderly, the degree of adherence was assessed with the Girerd score. Main outcome measure Percentage of prescriptions compliant with Beers Criteria and FHA guidelines. Results Among the 1206 prescriptions analysed, 67.49% (n = 814) contained a PIM. Only 12.77% (n = 154) complied with mandatory requirements of the FHA. Prescriptions were ordered by therapeutic field in 51.24% (n = 618) of cases. Dosing regimen was incomplete in 57.21% (n = 690) of prescriptions. Only 29.19% (n = 352) of patients reported no difficulty with regard to adherence (Girerd score = 0). The use of International Non-proprietary Name was associated with an increased risk of nonadherence (adjusted OR = 1.59 [95% CI = 1.13–2.23] and 1.68 [95% CI = 1.12–2.49] respectively). Patient satisfaction with formulation was associated with a lower risk of non-adherence (adjusted OR = 0.63 [95% CI = 0.45–0.90]). Conclusion A substantial proportion of patients are exposed to PIMs and prescriptions that do not comply with the FHA Guidelines. This issue, as well as identified risk factors for non-adherence, should be taken into consideration by general practitioners and community pharmacists when prescribing/dispensing medications to the elderly.

Keywords

Aged Community pharmacy Drug utilization review France Medication adherence Potentially inappropriate medication 

Notes

Acknowledgements

The authors would like to thank all community pharmacists and pharmacy students who contributed to this research. The authors would also like to thank patients who agreed to be interviewed for the purpose of this study. The kind assistance of Stella Ghouti for the proofreading and corrections of the English is gratefully acknowledged.

Funding

This research received no grant.

Conflicts of interest

The authors declare that they have no conflict of interest.

Supplementary material

11096_2017_531_MOESM1_ESM.pdf (102 kb)
Standardized questionnaire used to collect data and assess medication adherence

References

  1. 1.
    Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–95.CrossRefPubMedGoogle Scholar
  2. 2.
    Hughes CM, Cooper JA, Ryan C. Going beyond the numbers—a call to redefine polypharmacy. Br J Clin Pharmacol. 2014;77(6):915–6.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825–32.CrossRefPubMedGoogle Scholar
  4. 4.
    Fick D, Semla T, Beizer J, Dombrowski R, Brandt N, DuBeau CE, et al. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.CrossRefGoogle Scholar
  5. 5.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults—results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.CrossRefPubMedGoogle Scholar
  6. 6.
    American Geriatrics Society. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.CrossRefGoogle Scholar
  7. 7.
    O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47(8):891–6.CrossRefPubMedGoogle Scholar
  9. 9.
    McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156(3):385–91.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001;286(22):2823–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Laroche ML, Bouthier F, Merle L, Charmes JP. Potentially inappropriate medications in the elderly: interest of a list adapted to the French medical practice. Rev Med Interne. 2009;30(7):592–601.CrossRefPubMedGoogle Scholar
  12. 12.
    HAS. Prescription Médicamenteuse chez le Sujet Agé—Programme Pilote 2006–2013. 2011. http://www.has-sante.fr/portail/jcms/c_675707/fr/prescription-medicamenteuse-chez-le-sujet-age-pmsa-programme-pilote-2006-2013. Accessed 16 July 2017.
  13. 13.
    Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408–12.CrossRefPubMedGoogle Scholar
  14. 14.
    Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4(91):1–16.Google Scholar
  15. 15.
    Insel K, Morrow D, Brewer B, Figueredo A. Executive function, working memory, and medication adherence among older adults. J Gerontol B Psychol Sci Soc Sci. 2006;61(2):102–7.CrossRefGoogle Scholar
  16. 16.
    Witticke D, Seidling HM, Lohmann K, Send AF, Haefeli WE. Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in Germany. Drug Saf. 2013;36(1):31–41.CrossRefPubMedGoogle Scholar
  17. 17.
    Figueiredo D, Teixeira L, Poveda V, Paul C, Santos-Silva A, Costa E. Predictors of difficulty in medication intake in Europe: a cross-country analysis based on SHARE. Aging Dis. 2016;7(3):246–53.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.CrossRefPubMedGoogle Scholar
  19. 19.
    AFSSAPS. Mise au point. Prévenir la iatrogénèse médicamenteuse chez le sujet âgé. 2005. http://ansm.sante.fr/var/ansm_site/storage/original/application/9641eb3f4a1e67ba18a6b8aecd3f1985.pdf. Accessed 16 July 2017.
  20. 20.
    Girerd X, Radauceanu A, Achard JM, Fourcade J, Tournier B, Brillet G, et al. Evaluation of patient compliance among hypertensive patients treated by specialists. Arch Mal Coeur Vaiss. 2001;94(8):839–42.PubMedGoogle Scholar
  21. 21.
    Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, Vander Stichele R, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. 2016;82(5):1382–92.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Nishtala PS, Bagge ML, Campbell AJ, Tordoff JM. Potentially inappropriate medicines in a cohort of community-dwelling older people in New Zealand. Geriatr Gerontol Int. 2014;14(1):89–93.CrossRefPubMedGoogle Scholar
  23. 23.
    Kwint HF, Faber A, Gussekloo J, Bouvy ML. The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther. 2012;37(6):674–80.CrossRefPubMedGoogle Scholar
  24. 24.
    Franchi C, Cartabia M, Risso P, Mari D, Tettamanti M, Parabiaghi A, et al. Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project. Eur J Clin Pharmacol. 2013;69(7):1477–83.CrossRefPubMedGoogle Scholar
  25. 25.
    Hovstadius B, Petersson G, Hellstrom L, Ericson L. Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators. Drugs Aging. 2014;31(5):379–86.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Beer C, Hyde Z, Almeida OP, Norman P, Hankey GJ, Yeap BB, et al. Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol. 2011;71(4):592–9.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Payne RA, Avery AJ, Duerden M, Saunders CL, Simpson CR, Abel GA. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol. 2014;70(5):575–81.CrossRefPubMedGoogle Scholar
  28. 28.
    Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf. 2007;6(6):695–704.CrossRefPubMedGoogle Scholar
  29. 29.
    Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother. 2011;9(6):378–91.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415–27.CrossRefPubMedGoogle Scholar
  31. 31.
    Guaraldo L, Cano FG, Damasceno GS, Rozenfeld S. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatr. 2011;11:79.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Tiv M, Viel JF, Mauny F, Eschwege E, Weill A, Fournier C, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study. PLoS ONE. 2012;7(3):e32412.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Zelko E, Klemenc-Ketis Z, Tusek-Bunc K. Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies. Mater Sociomed. 2016;28(2):129–32.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Van Bever E, Elseviers M, Plovie M, Vandeputte L, Van Bortel L, Vander Stichele R. Attitudes of physicians and pharmacists towards International Non-proprietary Name prescribing in Belgium. Basic Clin Pharmacol Toxicol. 2015;116(3):264–72.CrossRefPubMedGoogle Scholar
  35. 35.
    Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303–12.CrossRefPubMedGoogle Scholar
  36. 36.
    Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Dumas S, Rouleau-Mailloux E, Bouchama N, Lahcene H, Talajic M, Tardif JC, et al. Pillbox use and INR stability in a prospective cohort of new warfarin users. J Manag Care Spec Pharm. 2016;22(6):676–84.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Faculté de PharmacieUniversité Paris-SudChatenay-MalabryFrance
  2. 2.Service de PharmacieAssistance Publique - Hôpitaux de Paris, Hôpital Saint-AntoineParisFrance
  3. 3.Service de PharmacieAssistance Publique - Hôpitaux de Paris, Hôpital Emile RouxLimeil-BrévannesFrance
  4. 4.Service de PharmacieAssistance Publique - Hôpitaux de Paris, Hôpital Européen Georges PompidouParisFrance
  5. 5.Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP UMRS 1136)ParisFrance

Personalised recommendations